Adalimumab Aacf + Abatacept Interaction

Majorinteraction on record

Description

Increased risk of serious infection when combined with ADALIMUMAB-AACF. Concomitant use is not recommended in patients with RA.

Mechanism

TNF blocker combined with biologic DMARD increases infection risk

Source: NLP:adalimumab-aacf